Natural Product: NPC331434

Natural Product IDNPC331434
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
MRAUNPAHJZDYCK-BYPYZUCNSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 28360916
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000347] Amino acids and derivatives
            • [CHEMONTID:0000060] Alpha amino acids and derivatives
              • [CHEMONTID:0002404] Alpha amino acids
                • [CHEMONTID:0004146] L-alpha-amino acids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey MRAUNPAHJZDYCK-BYPYZUCNSA-N
Standard InCHI InChI=1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1
SMILES C(C[C@@H](C(=O)O)N)CNC(=N)NN(=O)=O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   219.1 Volume:   194.568
?
Van der Waals volume.
Dense:   1.126 LogP:   -2.1
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -0.638
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.021
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   3.0
TPSA:   154.37
?
Topological Polar Surface Area.
H-Bond Acceptor:   9.0
H-Bond Donor:   6.0 Rings:   0.0
Heavy Atoms:   9.0

MedChem Properties

QED Drug-Likeness Score:   0.119 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.446 Fsp3:   0.667
MCE-18:   4.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.074 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.034 Promiscuous compounds:   0.188

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.02 MDCK Permeability:   -4.696
Pgp-inhibitor:   0.0 Pgp-substrate:   0.013
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.001 30% Bioavailability (F30%):   0.001
50% Bioavailability (F50%):   0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.892
Plasma Protein Binding (PPB):   19.372% Volume Distribution (VD):   -0.179
Fu: 81.815%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.91
OATP1B3 inhibitor:   0.994 BCRP inhibitor:   0.0
BSEP inhibitor:   0.002

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.243 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.405 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.007 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.002
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.207 Half-life (T1/2):  0.928

ADMET: Toxicity

hERG Blockers:  0.053 hERG Blockers (10um):  0.223
Human Hepatotoxicity (H-HT):  0.428 Drug-induced Liver Injury (DILI):  0.786
AMES Toxicity:  0.827 Rat Oral Acute Toxicity:  0.681
Maximum Recommended Daily Dose:  0.057 Skin Sensitization:  1.0
Carcinogencity:  0.359 Eye Corrosion:  0.002
Eye Irritation:  0.708 Respiratory Toxicity:  0.983
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.184
Hematotoxicity:  0.075 Drug-induced Nephrotoxicity:  0.747
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.024
A549 Cytotoxicity:  0.001 Hek293 Cytotoxicity:  0.691
BCF:   0.157
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.842
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.237
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.386
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40285 Phoma sp. NTOU4195 Strain Didymellaceae Eukaryota n.a. n.a. n.a. PMID[27976895]
NPO40162 Hoya kerrii Species Apocynaceae Eukaryota Stems n.a. n.a. PMID[28561586]
NPO40162 Hoya kerrii Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO40285 Phoma sp. NTOU4195 Strain Didymellaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens IC50 = 7600.0 nM PMID[9733492]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 600.0 nM PMID[9651169]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 14000.0 nM PMID[9651169]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens Ki = 670.0 nM PMID[9667974]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 80000.0 nM PMID[14698148]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 600.0 nM DOI[10.1016/0960-894X(96)00144-8]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 10000.0 nM DOI[10.1016/0960-894X(96)00144-8]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens IC50 = 5500.0 nM PMID[12781178]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 500.0 nM PMID[7525961]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens IC50 = 5500.0 nM PMID[12182860]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Ki = 4280.0 nM PMID[17425297]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 14740.0 nM PMID[17937988]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens Inhibition = 100.0 % PMID[19013076]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 6000.0 nM PMID[19537690]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 4000.0 nM PMID[19537690]
NPT3078 Individual protein N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Homo sapiens Inhibition = 6.0 % PMID[19013076]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens Inhibition = 91.0 % PMID[19013076]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Activity = 8.0 % PMID[19144449]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Activity = 15.0 % PMID[19144449]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus Activity = 2.0 % PMID[19144449]
NPT3517 Individual protein Nitric oxide synthase, inducible Homo sapiens Activity = 48.0 % PMID[19144449]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Ki = 570.0 nM PMID[20958055]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus Ki = 4550.0 nM PMID[20958055]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 152460.0 nM PMID[21846089]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 143550.0 nM PMID[22148193]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 5000.0 nM PMID[22370337]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus Ratio IC50 = 1.0 n.a. PMID[22370337]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 = 27550.0 nM PMID[33065432]
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 = 1400.0 nM PMID[36063653]
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Ki = 4400.0 nM PMID[36063653]
NPT4415 Individual protein Nitric-oxide synthase, endothelial Bos taurus IC50 = 1200.0 nM PMID[9651169]
NPT5867 Individual protein Nitric-oxide synthase, brain Mus musculus IC50 = 500.0 nM PMID[14698148]
NPT4415 Individual protein Nitric-oxide synthase, endothelial Bos taurus Ki = 720.0 nM PMID[17425297]
NPT4415 Individual protein Nitric-oxide synthase, endothelial Bos taurus Activity = 5.0 % PMID[19144449]
NPT4415 Individual protein Nitric-oxide synthase, endothelial Bos taurus Ki = 750.0 nM PMID[20958055]
NPT72 Individual protein Solute carrier organic anion transporter family member 1B3 Homo sapiens Inhibition = 113.76 % PMID[23571415]
NPT73 Individual protein Solute carrier organic anion transporter family member 1B1 Homo sapiens Inhibition = 113.37 % PMID[23571415]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 23.98 % DOI[10.6019/CHEMBL4495564]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 27.97 % DOI[10.6019/CHEMBL4495564]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 5.487 % DOI[10.6019/CHEMBL4495564]
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 103.83 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 0.7097 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 3.71 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens IC50 = 500.0 nM PMID[9733492]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens Ki = 15.0 nM PMID[9667974]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens IC50 = 80.0 nM PMID[12781178]
NPT15179 Single protein Nitric oxide synthase, inducible Rattus norvegicus IC50 = 20000.0 nM PMID[7525961]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens IC50 = 80.0 nM PMID[12182860]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens IC50 = 4400.0 nM PMID[19537690]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens Ki = 500.0 nM PMID[18477512]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens Inhibition = 100.0 % PMID[19013076]
NPT3569 Individual protein Nitric-oxide synthase, brain Homo sapiens Activity = 13.0 % PMID[19144449]
NPT29454 Single protein Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Homo sapiens Inhibition = 1.496 % PMID[38318365]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens IC50 = 500.0 nM PMID[9733492]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens Ki = 30.0 nM PMID[9667974]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens IC50 = 320.0 nM PMID[12781178]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens IC50 = 320.0 nM PMID[12182860]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens Inhibition = 100.0 % PMID[19013076]
NPT3974 Individual protein Nitric-oxide synthase, endothelial Homo sapiens Activity = 25.0 % PMID[19144449]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell line RAW264.7 Mus musculus IC50 = 43600.0 nM PMID[19715321]
NPT113 Cell line RAW264.7 Mus musculus Inhibition = 2.53 % PMID[19715321]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 146400.0 nM PMID[24597849]
NPT113 Cell line RAW264.7 Mus musculus Activity = 101.7 % PMID[27976895]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 144300.0 nM PMID[27976895]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 37700.0 nM PMID[28561586]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 2918.0 nM PMID[33065432]
NPT113 Cell line RAW264.7 Mus musculus IC50 = 39500.0 nM PMID[33422907]
NPT113 Cell line RAW264.7 Mus musculus CC50 > 100000.0 nM PMID[22148193]
NPT27045 Selectivity group Nitric oxide synthase (inducible and endothelial) Homo sapiens Ratio = 0.066 n.a. PMID[9733492]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -0.53 % DOI[10.21203/rs.3.rs-23951/v1]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -0.19 % DOI[10.6019/CHEMBL4495565]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.05 % DOI[10.6019/CHEMBL4495565]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.48 % DOI[10.6019/CHEMBL4495565]
NPT22974 Selectivity group Nitric oxide sythases; iNOS & nNOS Homo sapiens Ratio = 0.066 n.a. PMID[9733492]
NPT22974 Selectivity group Nitric oxide sythases; iNOS & nNOS Homo sapiens Ratio = 69.0 n.a. PMID[12182860]
NPT16957 Selectivity group Nitric-oxide synthase (endothelial and brain) Homo sapiens Ratio = 4.0 n.a. PMID[12182860]
NPT2 Others Unspecified n.a. Ki = 610.0 nM PMID[17425297]
NPT2 Others Unspecified n.a. Ratio Ki = 7.0 n.a. PMID[17425297]
NPT2 Others Unspecified n.a. Ratio Ki = 1.2 n.a. PMID[17425297]
NPT2 Others Unspecified n.a. Ratio IC50 = 0.7 n.a. PMID[19537690]
NPT2 Others Unspecified n.a. Ratio = 1.3 n.a. PMID[20958055]
NPT2 Others Unspecified n.a. Ratio = 8.0 n.a. PMID[20958055]
NPT2 Others Unspecified n.a. Ratio Ki = 293.0 n.a. PMID[23458846]
NPT2 Others Unspecified n.a. Ratio Ki = 11.0 n.a. PMID[23458846]
NPT2 Others Unspecified n.a. Ki = 15.0 nM PMID[23458846]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus IC50 = 200.0 nM PMID[9651169]
NPT29 Organism Rattus norvegicus Rattus norvegicus EC50 = 3000.0 nM PMID[9651169]
NPT29 Organism Rattus norvegicus Rattus norvegicus EC50 = 1100.0 nM PMID[10498190]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC331434 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6923 Remote Similarity NPC118429
0.6279 Remote Similarity NPC327985
0.5714 Remote Similarity NPC226453
0.5714 Remote Similarity NPC103130
0.5556 Remote Similarity NPC133183
0.5333 Remote Similarity NPC38059
0.5306 Remote Similarity NPC136091
0.5217 Remote Similarity NPC478501
0.52 Remote Similarity NPC601306

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC331434 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6923 Remote Similarity NPD9014 Phase 3
0.5714 Remote Similarity NPD9048 Phase 3
0.5581 Remote Similarity NPD9047 Phase 4
0.5333 Remote Similarity NPD9232 Phase 2
0.5333 Remote Similarity NPD9233 Phase 3
0.5306 Remote Similarity NPD9224 Phase 2
0.5217 Remote Similarity NPD9231 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data